218 related articles for article (PubMed ID: 26725899)
1. Universal screening for chronic hepatitis C virus.
Shiffman ML
Liver Int; 2016 Jan; 36 Suppl 1():62-6. PubMed ID: 26725899
[TBL] [Abstract][Full Text] [Related]
2. Estimates on HCV disease burden worldwide - filling the gaps.
Wedemeyer H; Dore GJ; Ward JW
J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
[TBL] [Abstract][Full Text] [Related]
3. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
4. Antiviral treatment for cirrhosis due to hepatitis C: a review.
Somasundaram A; Venkataraman J
Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
[TBL] [Abstract][Full Text] [Related]
5. Predicted effects of treatment for HCV infection vary among European countries.
Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
[TBL] [Abstract][Full Text] [Related]
6. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
Jacobson IM; Lim JK; Fried MW
Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.
Trinchet JC; Ganne-Carrié N; Nahon P; N'kontchou G; Beaugrand M
World J Gastroenterol; 2007 May; 13(17):2455-60. PubMed ID: 17552029
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Implications of Chronic Hepatitis C Virus Infection.
Hwang JP; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Torres HA; Bailey HH
J Oncol Pract; 2019 Dec; 15(12):629-637. PubMed ID: 31825756
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis C].
Grammatikos G; Sarrazin C
Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
[TBL] [Abstract][Full Text] [Related]
11. Heading Toward the Elimination of Hepatitis C Virus.
Kershenobich D; Torre-Delgadillo A; Aguilar-Valenzuela LM
Rev Invest Clin; 2018; 70(1):29-31. PubMed ID: 29513300
[TBL] [Abstract][Full Text] [Related]
12. Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis C virus.
Shiffman ML
Oncology; 2010 Jul; 78 Suppl 1():11-6. PubMed ID: 20616578
[TBL] [Abstract][Full Text] [Related]
13. Update on hepatitis C: epidemiology, treatment and resistance to antiviral therapies.
Ness E; Kowdley KV
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):145-58. PubMed ID: 25990619
[TBL] [Abstract][Full Text] [Related]
14. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
Masarone M; Persico M
Expert Rev Anti Infect Ther; 2011 May; 9(5):535-43. PubMed ID: 21609265
[TBL] [Abstract][Full Text] [Related]
16. Benefits of curing hepatitis C infection.
Marinho RT; Vitor S; Velosa J
J Gastrointestin Liver Dis; 2014 Mar; 23(1):85-90. PubMed ID: 24689102
[TBL] [Abstract][Full Text] [Related]
17. Natural history of hepatitis C and the impact of anti-viral therapy.
Boyer N; Marcellin P
Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
[TBL] [Abstract][Full Text] [Related]
18. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Michielsen P; Ho E; Francque S
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
[TBL] [Abstract][Full Text] [Related]
19. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Smith BD; Morgan RL; Beckett GA; Falck-Ytter Y; Holtzman D; Teo CG; Jewett A; Baack B; Rein DB; Patel N; Alter M; Yartel A; Ward JW;
MMWR Recomm Rep; 2012 Aug; 61(RR-4):1-32. PubMed ID: 22895429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
